C14ORF129 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.44089209850063E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.33066907387547E-16 |
Normal-vs-Stage2 |
1.86871999999783E-05 |
Normal-vs-Stage3 |
2.0176083026513E-12 |
Normal-vs-Stage4 |
8.24200041549261E-10 |
Stage1-vs-Stage2 |
4.994000E-01 |
Stage1-vs-Stage3 |
2.029000E-01 |
Stage1-vs-Stage4 |
5.163200E-01 |
Stage2-vs-Stage3 |
1.542010E-01 |
Stage2-vs-Stage4 |
3.097200E-01 |
Stage3-vs-Stage4 |
7.221400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6251444634463E-12 |
Normal-vs-AfricanAmerican |
4.55439996827067E-09 |
Normal-vs-Asian |
9.708400E-02 |
Caucasian-vs-AfricanAmerican |
6.360200E-01 |
Caucasian-vs-Asian |
5.316400E-01 |
AfricanAmerican-vs-Asian |
2.910400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.56461518688411E-14 |
Normal-vs-Female |
1.66344715779587E-12 |
Male-vs-Female |
7.001000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.43039999844774E-08 |
Normal-vs-Age(41-60Yrs) |
2.23188134640395E-12 |
Normal-vs-Age(61-80Yrs) |
1.62936331093988E-12 |
Normal-vs-Age(81-100Yrs) |
5.754500E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.115400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.589800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.385200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.617200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.953400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.133200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.814600E-04 |
Normal-vs-Grade 2 |
1.61459956515841E-10 |
Normal-vs-Grade 3 |
1.62458935193399E-12 |
Normal-vs-Grade 4 |
2.40185649147406E-12 |
Grade 1-vs-Grade 2 |
7.983600E-01 |
Grade 1-vs-Grade 3 |
8.175200E-01 |
Grade 1-vs-Grade 4 |
6.288000E-01 |
Grade 2-vs-Grade 3 |
1.614770E-01 |
Grade 2-vs-Grade 4 |
1.006770E-01 |
Grade 3-vs-Grade 4 |
5.966400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.62012633811537E-14 |
Normal-vs-ccB subtype |
1.53899999966178E-07 |
ccA subtype-vs-ccB subtype |
1.241110E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.0614182823856E-12 |
Normal-vs-N1 |
8.37470000000229E-05 |
N0-vs-N1 |
6.333400E-01 |
|
|